Navigation Links
Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome
Date:9/21/2007

somatropin is administered in combination with other drugs known to be metabolized by CP450 liver enzymes (e.g., corticosteroids, sex steroids, anticonvulsants, cyclosporine) or other hormone replacement therapy.

The safety and effectiveness of Norditropin in patients age 65 years and older has not been evaluated in clinical studies. Elderly patients may be more sensitive to the actions of somatropin and may be more prone to develop adverse reactions.

Common somatropin-related adverse reactions include injection site reactions/rashes, lipoatrophy and headaches, glucose intolerance, fluid retention and unmasking of latent central hypothyroidism.

Most serious adverse reactions include intracranial hypertension, diabetic retinopathy, glucose intolerance, slipped capital femoral epiphysis, progression of preexisting scoliosis, sudden death in pediatric patients with Prader-Willi syndrome with risk factors including severe obesity, history of upper airway obstruction or sleep apnea and unidentified respiratory infection, intracranial tumors as a 2nd tumor in patients who had been treated for a 1st neoplasm.

In clinical studies wherein children with Turner Syndrome were treated, the most frequently reported adverse events were common childhood diseases including influenza-like illness, otitis media, upper respiratory tract infection, otitis externa, gastroenteritis and eczema.

Patients with Turner syndrome should be evaluated carefully for otitis media and other ear disorders since these patients have an increased risk of ear and hearing disorders. Somatropin treatment may increase the occurrence of otitis media in patients with Turner Syndrome.

For more information including the prescribing information for Norditropin, please visit norditropin-us.com.

About Novo Nordisk

Novo Nordisk is a healthcare company and a world leader in diabetes care. The company has the broadest diabetes product portfolio in the industry, includin
'/>"/>

SOURCE Novo Nordisk
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Major Manufacturer of Unapproved and Adulterated Drugs
2. Survey: Migraine Patients Taking Potentially Addictive Barbiturate or Opioid Medications Not Approved by FDA as Migraine Treatments
3. Point of Care Strep Tests Speed Treatment, Lower Costs
4. Rapid HIV Testing Increases Possibility of Treatment
5. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
6. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
9. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
10. TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3 Trials
11. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... and ZURICH , May 17, 2013 /PRNewswire/ ... Science, Technology and Research (A*STAR) and Switzerland,s ... volunteer has been dosed in a Phase 1 clinical trial ... bacteriophage Qbeta virus-like particle (VLP) technology. In this first Phase ... vaccine candidate and its potential to protect against H1N1 influenza ...
(Date:5/16/2013)...  Nektar Therapeutics, (Nasdaq: NKTR ) President and ... is scheduled to present at the upcoming 2013 UBS Global ... the Sheraton New York Hotel on Tuesday, May 21, 2013 ... be accessible via a Webcast through a link posted in ... http://www.nektar.com . This Webcast will be available for replay ...
(Date:5/16/2013)... , May 16, 2013  Alere Inc. (NYSE: ... take charge of their health at home through the merger ... dividend of $3.00 per share on its Series B Convertible ... July 15, 2013 to holders of record of Series B ... Such payment will cover the amount of all ...
Breaking Medicine Technology:A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City 2
... Medical Alarm Concepts Holding, Inc. (OTCQB: MDHI.PK) today issued an ... with Carrollton, Texas based FirstFitness Nutrition Inc., a leading provider ... While both companies continue to move forward with ... both sides. Originally, the merger was projected to be finished ...
...  Nouveau Life Pharmaceuticals, soon to be changed from Hybrid Fuels, ... it is hiring a team of consumer marketing experts to ... portfolio of products to the market place. The ... and consumer education strategy for the Azul Instant™ product.  Consumer ...
Cached Medicine Technology:Medical Alarm Concepts Provides Update to Investors 2Medical Alarm Concepts Provides Update to Investors 3HRID Announces Growth and Expansion 2HRID Announces Growth and Expansion 3
(Date:5/19/2013)... 2013 According to a new ... Forecast (2013 – 2018): By Applications (Healthcare (Endoscopy, ... (CCD, CMOS, Contact IS, Infrared, X-Ray) And Geography" ... market was $8.00 billion in 2012 and is ... an estimated CAGR of 3.84% from 2013 to ...
(Date:5/19/2013)... May 19, 2013 Fat Burning Furnace ... program that provides people with fat burning diet ... order this Fat Burning Furnace package, people will receive ... they can download quickly. The Fat Burning Furnace manual ... people build lean muscle mass. In addition, this book ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 Dr. Keith Chertok ... help fight their unhealthy gums and increase the chance of ... Laser Assisted New Attachment Procedure (LANAP) not only removes diseased ... and strengthens the jaw bone for dental implants. ... diseased gum tissue. It can also help stimulate the healthy ...
(Date:5/19/2013)... 2013 Agora Health Limited developed by Rachael ... on how to increase memory power naturally and ... that helps people re-new their entire health from the inside ... caused by a fatigued mind. In addition, the program helps ... a lifetime. The author claimed that this program can help ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 Buenos Aires, Argentina: ... be offered in Buenos Aires, Argentina by the ... Sánchez de Bustamante 2372 - (Barrio Norte). Classes are ... The Yoga classes are offered in a calm environment, ... breathing exercises, and healthy vegetarian food, among others. , ...
Breaking Medicine News(10 mins):Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 3Health News:Fat Burning Diet | How “Fat Burning Furnace” Helps People Lose Their Weight Naturally And Fast – V-kool 2Health News:Berkeley, CA Periodontist, Dr. Keith Chertok Now Treats Gum Disease Patients With Laser Gum Surgery Prior to Placing Dental Implants 2Health News:How To Increase Memory Power | How “Agora Health Limited” Helps People Improve Their Memory Naturally And Effectively – Health Review 2Health News:Clases de Yoga in Buenos Aires, Argentina (Yoga Classes) Now Offered by Sivananda Yoga Vedanta Center 2
... ... of their new, pharmaceutical website, featuring an extensive selection of medications for the treatment ... ... popularly sold medications, with a particular emphasis on Erectile Dysfunction treatments. Erectile dysfunction, ...
... 9 The medical imaging market in Kenya is ... driven by an aging population demanding greater access to ... in the market remain high due to the sizeable ... financial constraints faced by many healthcare institutions in the ...
... 8 The Council for American Medical Innovation applauds President ... of life-threatening illnesses in Muslim nations. , , ... , In his address to the Muslim nation in ... must recognize that education and innovation will be the currency ...
... , SALT LAKE CITY, June 8 Qqest Software Systems ... company,s TimeForce time and attendance software, as well as the ... Colorado GI performs over 5,000 medical procedures each year. Prior ... were using a manual time clock and paper time cards ...
... KUNMING, China, June 8 /PRNewswire-Asia-FirstCall/ ... KUN) ("China Shenghuo" or,the "Company"), which is engaged ... nutritional supplement and cosmetic products,in the People,s Republic ... Amex,LLC (the "NYSE Amex" or "Exchange") has accepted ...
... Attorney General Eric Holder will be honored and deliver brief remarks ... Ceremony on TUESDAY, JUNE 9, 2009 at ... will present the Joel A. Toubin Memorial Award to the Attorney ... Holder , , WHAT: To be honored and ...
Cached Medicine News:Health News:Pro-Medics Launches Its New Line of Male Impotence Treatment Products 2Health News:Frost & Sullivan: Replacement of Old Equipment Boosts Kenyan Medical Imaging Industry 2Health News:Frost & Sullivan: Replacement of Old Equipment Boosts Kenyan Medical Imaging Industry 3Health News:Frost & Sullivan: Replacement of Old Equipment Boosts Kenyan Medical Imaging Industry 4Health News:Council for American Medical Innovation Applauds President Obama's Pledge to Invest in Science, Technology and Health Abroad 2Health News:Colorado Gastroenterology Chooses Qqest's TimeForce, Payroll Services 2Health News:NYSE Amex Accepts China Shenghuo's Compliance Plan for Continued Listing 2Health News:NYSE Amex Accepts China Shenghuo's Compliance Plan for Continued Listing 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: